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Abstract: Background: The current study investigates the cytotoxicity mechanism of common 
drugs with piperazine ring such as cetirizine, olanzapine and buspirone on human lymphocytes. 
Methods: The viability of lymphocytes, reactive oxygen species (ROS) formation, mitochondrial 
membrane potential (MMP) collapse, lysosomal integrity, content of glutathione and lipid peroxida-
tion was determined. 
Results: Buspirone and cetirizine showed more toxicity than olanzapine on human lymphocytes 
with an IC50 value of 200 μg/ml, after 6 h of incubation. Significant ROS formation, MMP col-
lapse, lipid peroxidation, lysosomal damage and elevation of glutathione disulfide (GSSG) were 
observed in treated lymphocytes concentrations (4, 20, 40 µg/ml) of buspirone and cetirizine. 
Conclusion: Our results show the exposure of human lymphocytes with buspirone and cetirizine, 
which usually happens during the poisoning, triggers oxidative stress and organelle damages. Our 
study suggests that using antioxidants, mitochondrial and lysosomal protective agents can protect 
blood lymphocytes, from probable side effects of these highly consumed medications. 
Keywords: Cetirizine, olanzapine, buspirone, toxicity, mitochondria, lysosome.
1. INTRODUCTION 
 Up to now, only about 27 million compounds have been 
recorded [1]. Among these chemical agents, drugs are a big 
family [2]. The physical, chemical and toxicological proper-
ties of this family are all related to the unique molecular 
structure [3]. 
 Drugs with piperazine ring appeared in the drug market 
for pharmacological purposes. Many drugs contain a 
piperazine ring such as antihistamines, antidepressants, an-
tipsychotics and etc. [4]. A large number of piperazine com-
pounds have antihistamine effects. One of these drugs is ceti-
rizine which inhibits H1 receptors and was used for the 
treatment of hay fever, allergies, angioedema, and urticaria. 
Cetirizine is now available over-the-counter (OTC) in many 
countries. Cetirizine was the highest-grossing new non-food 
product of 2008 in the United States (US). It is also available 
as a generic drug in Turkey, Iran, Australia, New Zealand 
and other countries [5]. Moreover, antipsychotic drugs such 
as olanzapine also contain a piperazine ring. Olanzapine is 
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an atypical antipsychotic drug and is approved for treatment 
of schizophrenia and bipolar disorder. The first-line psychi-
atric treatment for schizophrenia is antipsychotic medica-
tions which include olanzapine. There are several studies 
which have shown that olanzapine and its metabolites are 
toxic to normal cells [6, 7]. Another group of piperazine 
drugs is antidepressants. Buspirone belongs to this class. It is 
primarily used to treat generalized anxiety disorder (GAD). 
Cytotoxic effects of buspirone were reported [8]. 
 In humans, piperazine derivatives are readily absorbed 
from the gastrointestinal tract [9]. Therapeutic blood concen-
trations measured at clinical studies reached approximately 
0.02-0.3, 0.001-0.004, and 0.02-0.03 µg/ml for cetirizine, 
buspirone and olanzapine, respectively. On the other hand, 
toxic or lethal blood concentrations were reported for cetiriz-
ine, buspirone and olanzapine are 2-5, 2-3, and 1 µg/ml, re-
spectively [10]. 
 The immunotoxicity effects of drugs in lymphocytes, as 
an important cell in defense against foreign agents, result in 
infectious complications and virus-induced malignancies. A 
review of drug-induced immunotoxic effects demonstrates 
that immunotoxicity is a significant cause of morbidity and 
even mortality [11]. Our aim in this study was to evaluate 
toxic effects of piperazine-containing drugs including cetiriz-


A R T I C L E  H I S T O R Y
Received: September 17, 2017 
Revised: March 26, 2018 
Accepted: May 01, 2018 
 
DOI: 
10.2174/1574884713666180516112920 

2212-3938/18 $58.00+.00 © 2018 Bentham Science Publishers 
Toxicity of Drug with Piperazine Ring in Lymphocytes Current Clinical Pharmacology, 2018, Vol. 13, No. 2    121 
ine, buspirone and olanzapine by a cell-based method, to 
predict probable toxicity of these drugs in the severe over-
dose conditions. 
2. MATERIALS AND METHODS 
2.1. Chemistry 
 Trypan blue, 2′,7′-dichlorofluorescein diacetate (DCFH-
DA), Rhodamine123, bovine serum albumin (BSA), N-(2-
hydroxyethyl) piperazine-N′-(2-ethane sulfonic acid) 
(HEPES), RPMI1640 and FBS (Fetal Bovine serum) were 
purchased from Gibco, Life Technologies, Grand Island, 
NY. Ficoll-paque PLUS was obtained from Ge Healthcare 
Bio-Science. Cetirizine, buspirone and olanzapine, and all 
other chemicals with purity 99.9% were purchased from 
Sigma-Aldrich Corp. (Oakville, ON, Canada). 
2.2. Blood Samples 
 Blood samples (n=10) were obtained and approved by 
Blood Administration Center (Tehran, Iran). The studies 
were done at the School of Pharmacy, Shahid Beheshti Uni-
versity of Medical Sciences. All healthy individuals signed 
an informed consent form and this work was approved by the 
Shahid Beheshti University of Medical Sciences research 
ethics committee [12]. 
2.3. Lymphocytes Isolation 
 Lymphocytes were isolated from 10 healthy, non-
smoking volunteers at age range 25 to 35 years old, who 
showed no signs of infectious disease symptoms at the time 
sampling. Lymphocytes were isolated using Ficoll Paque 
Plus according to the manufacturer's instructions. After isola-
tion, lymphocytes were suspended in RPMI1640 medium 
with 10 % FBS and L-glutamine. The final lymphocytes 
concentration in the experiments was 1 × 10
6
 cells/ml. The 
viability of the lymphocytes was over 95 % [12]. 
2.4. Lymphocytes Treatment 
 Piperazine drugs were dissolved in DMSO with 0.05 % 
concentration. The concentrations of drugs were in the range 
of 4-400 µg/ml. The lymphocytes were incubated with com-
pounds for 6 h for analyzing of cell viability. Mechanistic 
oxidative parameters were searched within 3 h. The incuba-
tion was done at 37 °C in 5 % CO2 atmosphere [12]. 
2.5. Cell Viability 
 1×10
4
 cells/well were incubated in 96 well plates with 
and without piperazine drugs for 6 h. At the end of the test 
25 μl of MTT (5 mg/ml in RPMI) was added to each well 
and incubated for 1 h at 37 °C. MTT formazan crystals were 
dissolved in 100 μl of DMSO, and the absorbance was as-
sessed at 570 nm with ELISA reader. Each group was tested 
in three different experimental runs with three replicates for 
each sample [13]. 
2.6. Determination of ROS 
 To determine the rate of ROS generation induced by 
piperazine drugs in lymphocytes, dichlorofluorescein diace-
tate (DCFH-DA) with 1.6 µM concentration was added to 
the cells. This reagent penetrates into the cell and becomes 
hydrolyzed to non-fluorescent dichlorofluorescein (DCFH) 
then it reacts with ROS to form the highly fluorescent di-
chlorofluorescein (DCF). Cyclosporine A (Cs.A) as an MPT 
inhibitor and butylated hydroxyl toluene (BHT), an antioxi-
dant for more mechanistic approach, were used. The fluores-
cence intensity of DCF was assessed using a Shimadzu 
RF5000U fluorescence spectrophotometer. Excitation and 
emission wavelengths were 500 nm and 520 nm, respec-
tively. The results were presented here as fluorescent inten-
sity per 10
6
 cells [14, 15]. 
2.7. MMP Assay 
 Mitochondria uptake the cationic fluorescent dye of rho-
damine 123 (1.5 µM), and this reagent has been used for the 
assessment of mitochondrial membrane potential. The value 
of rhodamine 123 in the incubation medium was detected 
using a Shimadzu RF5000U fluorescence spectrophotometer 
set at 490 nm excitation and 520 nm emission wavelengths. 
The capacity of mitochondria to take up rhodamine 123 was 
calculated as a difference in rhodamine 123 fluorescence 
[14]. Also, Cyclosporine A (Cs.A) as an MPT inhibitor and 
butylated hydroxyl toluene (BHT), an antioxidant for more 
mechanistic approach, were used. 
2.8. Lysosomal Membrane Integrity Assay 
 Lymphocytes lysosomal membrane integrity was meas-
ured with the redistribution of the acridine orange as a fluo-
rescent dye for lysosomal damages. Cell suspension (0.5 
mL) that was previously dyed with acridine orange (5 µM) 
was separated from the incubation medium by centrifuge (1 
1000 g× 1 min). Lymphocytes washing was performed twice 
to remove the fluorescent dye. Cyclosporine A (Cs.A) as an 
MPT inhibitor and butylated hydroxyl toluene (BHT), an 
antioxidant for more mechanistic approach, were used. 
Acridine orange redistribution in the lymphocyte suspension 
was then determined fluorometrically using a Shimadzu 
RF5000U fluorescence spectrophotometer set at 495 nm 
excitation and 530 nm emission wavelengths [15]. 
2.9. Lipid Peroxidation 
 For measurement of lipid peroxidation in treated cell, this 
test was conducted by determining the amount of malondial-
dehyde (MDA) formed during the decomposition of lipid 
hydroperoxides by following the absorbance at 532 nm in a 
Beckman DU-7 spectrophotometer [16]. Also, Cyclosporine 
A (Cs.A) as an MPT inhibitor and butylated hydroxyl tolu-
ene (BHT), an antioxidant for more mechanistic approach, 
were used. 
2.10. Glutathione (GSH) and Glutathione Disulfide (GSSG) 
 GSH and GSSG were measured according to the spectro-
fluorometric method. Each sample was measured in quartz 
cuvettes using a fluorimeter set at 350 nm excitation and 420 
nm emission wavelengths [16]. 
2.11. Statistical Analysis 
 Data were presented as mean ± SD. Assays were done in 
triplicate and the mean was used for statistical analysis. Sta-
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tistical significance was determined using the one-way 
ANOVA test, followed by the post-hoc Tukey test when 
appropriate. Statistical significance was set at P < 0.05. 
3. RESULTS 
3.1. Cell Viability 
 Drugs were tested on lymphocytes and indicated a sig-
nificant decrease in cell viability. Among them, buspirone 
showed maximum cytotoxic activity. The toxic effect is pre-
sumed to be due to the bulkier size. The order of cytotoxicity 
of these drugs measured by MTT assay is buspirone > ceti-
rizine > olanzapine, Fig. (2A-C). 
3.2. ROS Formation 
 As shown in Fig. (3), treatment of the lymphocytes with 
cetirizine and buspirone at concentrations (4, 20, 40 µg/ml) 
which are much less than their IC50 resulted in significant 
(P<0.05) increased ROS formation compared to the control 
lymphocytes, but for olanzapine ROS formation observed at 
the last time interval (3 h) only by the highest-used concen-
tration (40 µg/ml). These changes were in accordance with 
the order of cytotoxic activity of the tested drugs buspirone > 
cetirizine > olanzapine (Fig. 3). 
3.3. MMP Collapse 
 For measurement of the mitochondrial membrane poten-
tial, mitochondria were dyed with rhodamine 123. Incuba-
tion of lymphocytes with 4, 20 and 40 μg/ml of cetirizine 
and buspirone for 3 hours led to a mitochondrial membrane 
potential collapse compared to untreated control lympho-
cytes. Again, for olanzapine, mitochondrial collapse was 
observed only at the highest concentration (40 µg/ml) (Fig. 4). 
These results were also in accordance with the order of ROS 
formation and cytotoxicity recorded for these dugs. 
3.4. Lysosomal Integrity 
 As shown in Fig. (5), there was a loss of lysosomal integ-
rity expressed by a decrease in the uptake of acridine orange 
when lymphocytes were exposed to cetirizine and buspirone 
Fig. (1). Chemical structure of drugs, Cetirizine (A), buspirone (B) and olanzapine (C). 
Fig. (2). Cytotoxicity, lymphocyte from normal donors, at 1 × 10
4
 cells/well, was seeded on 96-well plates. Cetirizine (A), buspirone (B) and 
olanzapine (C) at 4-400 µg/ml concentrations were incubated for 6 h. The absorbance representing the viability of lymphocyte was deter-
mined by the ELISA reader at 570 nm. Data presented as mean ± SD. The significant level was P <0.05 n =5. ** And *** indicate significant 
(P <0. 01) and (P <0.001) with untreated control respectively. ns indicates non-significant with control. 
Buspirone Cetirizine Olanzapine
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at concentrations (4, 20 and 40 µg/ml) within 3 h. The loss of 
lysosomal integrity occurred in a concentration-dependent 
manner for both drugs within 3 h. Just in case which lym-
phocytes were incubated with olanzapine for 3h, significant 
lysosomal damage was occurred only at a concentration of 
40 µg/ml. 
 
Fig. (3). ROS measurement in lymphocytes after exposure with cetirizine (A), buspirone (B) and olanzapine (C) at 4, 20 and 40 concentra-
tions within 3h. ROS formation was determined fluorometrically using DCF-DA as described in materials and methods. Values are presented 
as percent (n = 5). *** represents P < 0.001 significant difference compared to untreated control. ### represents P < 0.001 significant differ-
ence compared to 20 µg/ml for each compound. ns indicates non-significant with control. 
Fig. (4). MMP decline in lymphocytes after treatment with cetirizine (A), buspirone (B) and olanzapine (C) at 4, 20 and 40 µg/ml concentra-
tions within 3h. Drug-treated compared to those of untreated control. Collapse of MMP was measured by rhodamine 123. Butylated hy-
droxytoluene (BHT) and MPT pore sealing agents Cyclosporine, A (Cs. A) inhibited the decline of MMP in lymphocytes exposed to 20 or 
40 µg/ml for each compound. Values represented as percent of MMP decline (n = 5). *** Represents significant difference (P< 0. 001) com-
pared to control. 
###
 Represents significant difference (P< 0.001) compared to 20 or 40 µg/ml of each compound. ns indicates non-significant 
with control. 
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3.5. Lipid Peroxidation 
 The ability of the above-mentioned drugs to cause lipid 
peroxidation in lymphocytes was measured by measuring 
MDA formation. As shown in Fig. (6), buspirone caused 
significant (P<0.05) MDA formation during the 3h incuba-
tion at all concentrations (4, 20 and 40 µg/ml) used. But for 
cetirizine and olanzapine, significant (P<0.05) MDA forma-
tion could only be observed when lymphocytes were treated 
with the highest concentration (40 µg/ml). 
Fig. (5). Lysosomal membrane damage after treatment with cetirizine (A), buspirone (B) and olanzapine (C) at lymphocytes at 4, 20 and  
40 µg/ml concentrations within 3h. Lysosomal membrane damage was measured as a described in materials and methods. Results were 
shown as % lysosomal membrane leakiness in all treated groups. Values are expressed as mean ± SD of three separate experiments (n = 5).  
*** Significant difference in comparison with drug treated lymphocytes with control (p < 0.001). ns indicates non-significant with control. 
###
 Represents significant difference (P< 0.001) compared to 20 or 40 µg/ml of each compound. 
 
Fig. (6). Lipid peroxidation after treatment with cetirizine (A), buspirone (B) and olanzapine (C) at lymphocytes at 4, 20 and 40 µg/ml con-
centrations within 3h. Lymphocytes (10
6
 cells/ml) were incubated in the RPMI 1640 at 37 
o
C for 3 h after the addition of drugs. TBARS 
formation was presented as nM concentrations. Values are presented as mean ± SD of three separate experiments (n = 5). *** Significant 
difference in comparison with untreated control lymphocytes (p < 0.001). ### Significant difference in comparison with drug-treated lym-
phocytes (20 or 40 µg/ml) and preventive agent (BHT, GSH and Cs. A) (p < 0.001). 
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3.6. Glutathione Levels 
 As shown in Fig. (7), GSH and GSSG levels were meas-
ured under the same experimental condition and correlated 
with MDA formation and other measured parameters. A sig-
nificant decrease in GSH level was indicated when lympho-
cytes were treated with 20 and 40 µg/ml of buspirone and 
cetirizine within 3h which was consequent by an increase in 
GSSG levels in the treated lymphocytes. There was no sig-
nificant change in GSH and GSSG levels when lymphocytes 
were exposed to olanzapine under the same condition. 
4. DISCUSSION 
 The properties of a compound such as physical, chemical 
and toxicological properties are all derived from and related 
to the unique molecular structure of that compound. This 
principle forms the basis for the prediction of toxicity from 
chemical structure [3]. The biological activity of a chemical 
agent depends on two factors. First, its transformation from 
the site of administration to the site of action; then its bind-
ing or reaction with a receptor or target [1]. In this paper, we 
studied the cytotoxicity of three drugs with piperazine ring 
on human blood lymphocytes. A recent survey found that 
cetirizine, buspirone and olanzapine are amongst the most 
common drugs with piperazine ring [17]. Our findings 
showed that all these drugs caused cytotoxicity on human 
lymphocytes, among them buspirone was the most potent 
drug to elicit cytotoxic effects. 
 Oxidative stress is a well-described mechanism which 
plays an essential role in the cytotoxic effects of several 
piperazine derivatives that induce the formation of highly 
reactive species [17]. Interestingly, we found that cetirizine 
and buspirone significantly increase reactive oxygen species 
(ROS) formation, as measured through the DCFH-DA assay 
(Fig. 3). 
 Our data also revealed that cetirizine, buspirone and 
olanzapine alter the mitochondrial depolarization, leading to 
MMP collapse, which was interestingly inhibited by pre-
treatment of antioxidant (Butylated hydroxytoluene or BHT) 
and MPT pore-sealing agents (Cyclosporine, A or Cs.A). 
After mitochondrial depolarization in the cell, the ATP syn-
thase returns to ATPase activity, consuming ATP and pump-
ing protons outward, in a futile energy-consuming cycle 
[18]. Other studies conducted with buspirone and olanzapine 
similarly have demonstrated an MMP collapse (ΔΨm) in the 
cytotoxic effects of these drugs [6, 8]. To confirm that MMP 
collapse (ΔΨm) induced by piperazine drugs results from 
mitochondrial permeability transition pore(s) (MPTP) open-
ing, we pre-incubated lymphocytes with Cyclosporine A (Cs. 
A), which binds to cyclophilin D, a part of the MPTP,  
which causes inhibition of the MPTP opening and prevents  
 
Fig. (7). Intracellular GSH (A1, B1 and C1) and extracellular GSSG ((A2, B2 and C2) after treatment with cetirizine (A), buspirone (B) and 
olanzapine (C) at lymphocytes at 4, 20 and 40 µg/ml concentrations within 3h. Lymphocytes (10
6
 cells/ml) were incubated in the RPMI 1640 
at 37
o
C for 3 h after the addition of drugs. Intracellular GSH (A1, B1 and C1) and extra cellular GSSG (A2, B2 and C2) were fluorimetri-
cally measured. BHT and Cs. A inhibited the decline of GSH in lymphocytes exposed to 20 or 40 µg/ml for each compound. Values are ex-
pressed as mean ± SD of three separate experiments (n = 5). *** Significant difference in comparison with control (p < 0.001). ns indicates 
non-significant with control. 
###
 Represents significant difference (P< 0.001) compared to 20 or 40 µg/ml of each compound. ns indicates 
non-significant with control. 
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mitochondrial collapse. Our results showed that incubation 
with Cs.A partially but significantly (P<0.05) prevented 
MMP collapse induced by the tested drugs. Piperazine drug-
induced MMP collapse (ΔΨm) was also prevented by the 
ROS scavenger (BHT) suggesting the involvement of in-
creased ROS formation in mitochondrial permeability transi-
tion pore(s) (MPTP) opening. 
 When the loaded lymphocytes were treated with cetiriz-
ine and buspirone, indicating leakiness of the lysosomal 
membrane (Fig. 5). On the other hand, this drug-induced 
lysosomal membrane leakiness was prevented by the ROS 
scavenger (BHT) and lysosomal pH enhancer, Chloroquine. 
It is assumed that oxidative stress damages both mitochon-
drial and lysosomal membranes following piperazine drug-
induced ROS formation, which leads to cell death. 
 GSH has an important protective role in oxidant neutrali-
zation. Changes in the intracellular amounts of GSH and 
GSSG are, therefore, powerful indexes of redox disturbances 
[19]. In agreement with ROS formation data, the intracellular 
GSH level significantly changed upon incubation with buspi-
rone and cetirizine with the exception of olanzapine. Our 
data showed a decrease in the intracellular GSH content, 
accompanied by a significant increase in GSSG levels (Fig. 7). 
 It was suggested that lipid peroxidation could have a 
main role in the toxicity induced by some drugs [20]. The 
results of the present study also showed that treatment of 
lymphocytes with buspirone and cetirizine provoked lipid 
peroxidation in plasma membrane as well as sub-cellular 
organelle membranes of lymphocytes. Our results suggest 
that buspirone compared to other piperazine drugs acts as a 
much stronger pro-oxidant in human blood lymphocytes 
even at sub-toxic concentrations. 
CONCLUSION 
 In conclusion, this research for the first time studied the 
cytotoxicity of cetirizine, buspirone and olanzapine in an ex 
vivo model, human blood lymphocytes at concentrations 
much less than IC50. Among three tested drugs, buspirone 
was the most potent at increasing cytotoxicity parameters. 
All cetirizine, buspirone and olanzapine induced oxidative 
stress in human lymphocytes through ROS formation, lead-
ing to mitochondrial and lysosomal damages, and GSH de-
pletion. It should be noted that these drugs are frequently 
consumed in many diseases. We can now conclude that sub-
cellular organelle damages and oxidative stress are involved 
in the toxic effects of these drugs in high overdosed or ac-
cumulated concentrations. 
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